Report Detail
Global (United States, European Union and China) Anti-Obesity Prescription Market Research Report 2019-2025
- RnM3648220 |
- 06 August, 2019 |
- Global |
- 114 Pages |
- QYResearch |
- Pharma & Healthcare
Obesity is a public health problem. Obesity is a genetic and chronic metabolic disease involving accumulation of excessive or abnormal fat in the body. It contributes to risk of chronic conditions such as cancer, hypertension, cardiovascular diseases, diabetics, obstructive sleep apnea, ventilatory failure, renal failure and asthma. According to a World Health Organization (WHO) report published in 2014, around 3.4 million adults in the world die each year due to obesity related issues. Increasing prevalence of obesity among children and adults is posing a threat and developing nations. Effective intervention strategies such as increased physical activity, behavioral and dietary changes are commonly used to control and prevent obesity. Obesity has a major impact on population longevity and health related expense.
There is increased use of anti-obesity prescription due to increasing obesity endemic. Sedentary lifestyle and junk food habits, increasing healthcare expenditure and rise in aging population are some of the key factors driving the growth for global anti-obesity prescription market. In addition, increasing healthcare awareness is also fuelling the growth of the global anti-obesity prescription market. However, side effects of anti-obesity drugs, high drug development cost and strict regulatory framework are some of the major factors restraining the growth for the global anti-obesity prescription market.
In 2019, the market size of Anti-Obesity Prescription is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Anti-Obesity Prescription.
This report studies the global market size of Anti-Obesity Prescription, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Anti-Obesity Prescription sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.
In global market, the following companies are covered:
Zydus Cadila
Akrimax Pharmaceuticals
Zealand Pharma
Arrowhead Research
Arena Pharmaceuticals
Compellis Pharmaceuticals
Yungjin Pharm
Alpex Pharma
Bridge BioResearch
Market Segment by Product Type
Bupropion and Naltrexone
Orlistat
Lorcaserin
Phentermine and Topiramate
Liraglutide
Market Segment by Application
Hospital Pharmacies
Retail Pharmacies
E-Commerce
Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)
The study objectives are:
To analyze and research the Anti-Obesity Prescription status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Anti-Obesity Prescription manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
In this study, the years considered to estimate the market size of Anti-Obesity Prescription are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
Table of Contents
1 Report Overview
- 1.1 Study Scope
- 1.2 Major Manufacturers Covered in This Report
- 1.3 Market Segment by Type
- 1.3.1 Global Anti-Obesity Prescription Market Size Growth Rate by Type (2019-2025)
- 1.3.2 Bupropion and Naltrexone
- 1.3.3 Orlistat
- 1.3.4 Lorcaserin
- 1.3.5 Phentermine and Topiramate
- 1.3.6 Liraglutide
- 1.4 Market Segment by Application
- 1.4.1 Global Anti-Obesity Prescription Market Share by Application (2019-2025)
- 1.4.2 Hospital Pharmacies
- 1.4.3 Retail Pharmacies
- 1.4.4 E-Commerce
- 1.5 Study Objectives
- 1.6 Years Considered
2 Global Growth Trends
- 2.1 Global Anti-Obesity Prescription Market Size
- 2.1.1 Global Anti-Obesity Prescription Revenue 2014-2025
- 2.1.2 Global Anti-Obesity Prescription Sales 2014-2025
- 2.2 Anti-Obesity Prescription Growth Rate by Regions
- 2.2.1 Global Anti-Obesity Prescription Sales by Regions 2014-2019
- 2.2.2 Global Anti-Obesity Prescription Revenue by Regions 2014-2019
- 2.3 Industry Trends
- 2.3.1 Market Top Trends
- 2.3.2 Market Drivers
3 Market Share by Manufacturers
- 3.1 Anti-Obesity Prescription Sales by Manufacturers
- 3.1.1 Anti-Obesity Prescription Sales by Manufacturers 2014-2019
- 3.1.2 Anti-Obesity Prescription Sales Market Share by Manufacturers 2014-2019
- 3.2 Revenue by Manufacturers
- 3.2.1 Anti-Obesity Prescription Revenue by Manufacturers (2014-2019)
- 3.2.2 Anti-Obesity Prescription Revenue Share by Manufacturers (2014-2019)
- 3.2.3 Global Anti-Obesity Prescription Market Concentration Ratio (CR5 and HHI)
- 3.3 Anti-Obesity Prescription Price by Manufacturers
- 3.4 Key Manufacturers Anti-Obesity Prescription Plants/Factories Distribution and Area Served
- 3.5 Date of Key Manufacturers Enter into Anti-Obesity Prescription Market
- 3.6 Key Manufacturers Anti-Obesity Prescription Product Offered
- 3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
- 4.1 Sales and Revenue for Each Type
- 4.1.1 Bupropion and Naltrexone Sales and Revenue (2014-2019)
- 4.1.2 Orlistat Sales and Revenue (2014-2019)
- 4.1.3 Lorcaserin Sales and Revenue (2014-2019)
- 4.1.4 Phentermine and Topiramate Sales and Revenue (2014-2019)
- 4.1.5 Liraglutide Sales and Revenue (2014-2019)
- 4.2 Global Anti-Obesity Prescription Sales Market Share by Type
- 4.3 Global Anti-Obesity Prescription Revenue Market Share by Type
- 4.4 Anti-Obesity Prescription Price by Type
5 Market Size by Application
- 5.1 Overview
- 5.2 Global Anti-Obesity Prescription Sales by Application
6 United States
- 6.1 United States Anti-Obesity Prescription Breakdown Data by Company
- 6.2 United States Anti-Obesity Prescription Breakdown Data by Type
- 6.3 United States Anti-Obesity Prescription Breakdown Data by Application
7 European Union
- 7.1 European Union Anti-Obesity Prescription Breakdown Data by Company
- 7.2 European Union Anti-Obesity Prescription Breakdown Data by Type
- 7.3 European Union Anti-Obesity Prescription Breakdown Data by Application
8 China
- 8.1 China Anti-Obesity Prescription Breakdown Data by Company
- 8.2 China Anti-Obesity Prescription Breakdown Data by Type
- 8.3 China Anti-Obesity Prescription Breakdown Data by Application
9 Rest of World
- 9.1 Rest of World Anti-Obesity Prescription Breakdown Data by Company
- 9.2 Rest of World Anti-Obesity Prescription Breakdown Data by Type
- 9.3 Rest of World Anti-Obesity Prescription Breakdown Data by Application
- 9.4 Rest of World Anti-Obesity Prescription Breakdown Data by Countries
- 9.4.1 Rest of World Anti-Obesity Prescription Sales by Countries
- 9.4.2 Rest of World Anti-Obesity Prescription Revenue by Countries
- 9.4.3 Japan
- 9.4.4 Korea
- 9.4.5 India
- 9.4.6 Southeast Asia
10 Company Profiles
- 10.1 Zydus Cadila
- 10.1.1 Zydus Cadila Company Details
- 10.1.2 Company Description and Business Overview
- 10.1.3 Sales, Revenue and Market Share of Anti-Obesity Prescription
- 10.1.4 Anti-Obesity Prescription Product Introduction
- 10.1.5 Zydus Cadila Recent Development
- 10.2 Akrimax Pharmaceuticals
- 10.2.1 Akrimax Pharmaceuticals Company Details
- 10.2.2 Company Description and Business Overview
- 10.2.3 Sales, Revenue and Market Share of Anti-Obesity Prescription
- 10.2.4 Anti-Obesity Prescription Product Introduction
- 10.2.5 Akrimax Pharmaceuticals Recent Development
- 10.3 Zealand Pharma
- 10.3.1 Zealand Pharma Company Details
- 10.3.2 Company Description and Business Overview
- 10.3.3 Sales, Revenue and Market Share of Anti-Obesity Prescription
- 10.3.4 Anti-Obesity Prescription Product Introduction
- 10.3.5 Zealand Pharma Recent Development
- 10.4 Arrowhead Research
- 10.4.1 Arrowhead Research Company Details
- 10.4.2 Company Description and Business Overview
- 10.4.3 Sales, Revenue and Market Share of Anti-Obesity Prescription
- 10.4.4 Anti-Obesity Prescription Product Introduction
- 10.4.5 Arrowhead Research Recent Development
- 10.5 Arena Pharmaceuticals
- 10.5.1 Arena Pharmaceuticals Company Details
- 10.5.2 Company Description and Business Overview
- 10.5.3 Sales, Revenue and Market Share of Anti-Obesity Prescription
- 10.5.4 Anti-Obesity Prescription Product Introduction
- 10.5.5 Arena Pharmaceuticals Recent Development
- 10.6 Compellis Pharmaceuticals
- 10.6.1 Compellis Pharmaceuticals Company Details
- 10.6.2 Company Description and Business Overview
- 10.6.3 Sales, Revenue and Market Share of Anti-Obesity Prescription
- 10.6.4 Anti-Obesity Prescription Product Introduction
- 10.6.5 Compellis Pharmaceuticals Recent Development
- 10.7 Yungjin Pharm
- 10.7.1 Yungjin Pharm Company Details
- 10.7.2 Company Description and Business Overview
- 10.7.3 Sales, Revenue and Market Share of Anti-Obesity Prescription
- 10.7.4 Anti-Obesity Prescription Product Introduction
- 10.7.5 Yungjin Pharm Recent Development
- 10.8 Alpex Pharma
- 10.8.1 Alpex Pharma Company Details
- 10.8.2 Company Description and Business Overview
- 10.8.3 Sales, Revenue and Market Share of Anti-Obesity Prescription
- 10.8.4 Anti-Obesity Prescription Product Introduction
- 10.8.5 Alpex Pharma Recent Development
- 10.9 Bridge BioResearch
- 10.9.1 Bridge BioResearch Company Details
- 10.9.2 Company Description and Business Overview
- 10.9.3 Sales, Revenue and Market Share of Anti-Obesity Prescription
- 10.9.4 Anti-Obesity Prescription Product Introduction
- 10.9.5 Bridge BioResearch Recent Development
11 Value Chain and Sales Channels Analysis
- 11.1 Value Chain Analysis
- 11.2 Sales Channels Analysis
- 11.2.1 Anti-Obesity Prescription Sales Channels
- 11.2.2 Anti-Obesity Prescription Distributors
- 11.3 Anti-Obesity Prescription Customers
12 Market Forecast
- 12.1 Global Anti-Obesity Prescription Sales and Revenue Forecast 2019-2025
- 12.2 Global Anti-Obesity Prescription Sales Forecast by Type
- 12.3 Global Anti-Obesity Prescription Sales Forecast by Application
- 12.4 Anti-Obesity Prescription Forecast by Regions
- 12.4.1 Global Anti-Obesity Prescription Sales Forecast by Regions 2019-2025
- 12.4.2 Global Anti-Obesity Prescription Revenue Forecast by Regions 2019-2025
- 12.5 United States Market Forecast
- 12.6 European Union Market Forecast
- 12.7 China Market Forecast
- 12.8 Rest of World
- 12.8.1 Japan
- 12.8.2 Korea
- 12.8.3 India
13 Research Findings and Conclusion
14 Appendix
- 14.1 Research Methodology
- 14.1.1 Methodology/Research Approach
- 14.1.1.1 Research Programs/Design
- 14.1.1.2 Market Size Estimation
- 14.1.1.3 Market Breakdown and Data Triangulation
- 14.1.2 Data Source
- 14.1.2.1 Secondary Sources
- 14.1.2.2 Primary Sources
- 14.1.1 Methodology/Research Approach
- 14.2 Author Details
Summary:
Get latest Market Research Reports on Anti-Obesity Prescription. Industry analysis & Market Report on Anti-Obesity Prescription is a syndicated market report, published as Global (United States, European Union and China) Anti-Obesity Prescription Market Research Report 2019-2025. It is complete Research Study and Industry Analysis of Anti-Obesity Prescription market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
